Drug Shortage Report for ERYTHRO-ES
| Report ID | 3752 |
| Drug Identification Number | 00637416 |
| Brand name | ERYTHRO-ES |
| Common or Proper name | ERYTHRO-ES |
| Company Name | AA PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ERYTHROMYCIN |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 Bottle |
| ATC code | J01FA |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2015-06-24 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2019-01-15 |
| Shortage status | Resolved |
| Updated date | 2020-08-06 |
| Company comments | product discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-21 | English | Compare |
| v2 | 2017-03-21 | French | Compare |
| v3 | 2020-08-06 | English | Compare |
| v4 | 2020-08-06 | French | Compare |
Showing 1 to 4 of 4